Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity
Artificial Organs · 2025
DOI: 10.1111/aor.15000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Mohammad Reza Movahed und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona Sarver Heart Center, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Obesity, Morbid, Overweight, Shock, Cardiogenic. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Mortality of cardiogenic shock remains high, prompting increased use of mechanical circulatory support devices such as Impella. This study sought to characterize whether weight categories predict mortality in patients who received Impella devices.
Methods
We used data from the National Inpatient Sample (NIS) database from the years 2016 to 2020 and ICD‐10‐CM/PCS codes to evaluate the effect of weight categories on mortality in patients undergoing Impella implantation.
Results
A total of 86 810 patients underwent Impella device implantation, with an overall mortality of 29.85%. Mortality for normal weight was 30.4%, similar to cachexia (30.3%) and morbidly obese patients (31.1%). However, the overweight and obese categories had the lowest mortality (13.4% and 24.9%, p < 0.0001). Using multivariate analysis adjusting for comorbid conditions, overweight and obesity remained significantly associated with the lowest mortality (overweight: OR: 0.3, CI: 0.16–0.68, p = 0.003, Obese: OR: 0.8, CI: 0.71–0.91, p < 001) whereas morbid obesity was associated with the highest mortality (OR: 1.17, CI: 1.02–1.34, p = 0.02).
Conclusion
Using a large database, we found that overweight and obesity have a protective effect on mortality in patients undergoing Impella insertion. However, morbid obesity appears to have detrimental effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Arizona Sarver Heart Center, Tucson, Arizona, USA.
- University of Arizona College of Medicine, Phoenix, Arizona, USA.
ORCID-Profile: Mohammad Reza Movahed, Spencer Bradshaw
Zitieren
APA
Movahed, M. R., Bradshaw, S., & Hashemzadeh, M. (2025). Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity. Artificial Organs. https://doi.org/10.1111/aor.15000
Vancouver
Movahed MR, Bradshaw S, Hashemzadeh M. Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity. Artificial Organs. 2025. doi:10.1111/aor.15000
BibTeX
@article{Movahed2025,
author = {Movahed, Mohammad Reza and Bradshaw, Spencer and Hashemzadeh, Mehrtash},
title = {Mortality With Impella Is Lowest in Overweight and Obese but Is Highest in Morbid Obesity},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.15000}
}
EUVIMED